200 related articles for article (PubMed ID: 32295599)
1. Sustained-release voriconazole-thermogel for subconjunctival injection in horses: ocular toxicity and in-vivo studies.
Mora-Pereira M; Abarca EM; Duran S; Ravis W; McMullen RJ; Fischer BM; Lee YP; Wooldridge AA
BMC Vet Res; 2020 Apr; 16(1):115. PubMed ID: 32295599
[TBL] [Abstract][Full Text] [Related]
2. Development of a Sustained-Release Voriconazole-Containing Thermogel for Subconjunctival Injection in Horses.
Cuming RS; Abarca EM; Duran S; Wooldridge AA; Stewart AJ; Ravis W; Babu RJ; Lin YJ; Hathcock T
Invest Ophthalmol Vis Sci; 2017 May; 58(5):2746-2754. PubMed ID: 28549089
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of concentration of voriconazole in aqueous humor after topical and oral administration in horses.
Clode AB; Davis JL; Salmon J; Michau TM; Gilger BC
Am J Vet Res; 2006 Feb; 67(2):296-301. PubMed ID: 16454636
[TBL] [Abstract][Full Text] [Related]
4. Aqueous humor concentration of voriconazole after topical administration in rabbits.
Vorwerk CK; Streit F; Binder L; Tuchen S; Knop C; Behrens-Baumann W
Graefes Arch Clin Exp Ophthalmol; 2008 Aug; 246(8):1179-83. PubMed ID: 18491124
[TBL] [Abstract][Full Text] [Related]
5. Utility of systemic voriconazole in equine keratomycosis based on pharmacokinetic-pharmacodynamic analysis of tear fluid following oral administration.
Tamura N; Okano A; Kuroda T; Niwa H; Kusano K; Matsuda Y; Fukuda K; Mita H; Nagata S
Vet Ophthalmol; 2020 Jul; 23(4):640-647. PubMed ID: 32383526
[TBL] [Abstract][Full Text] [Related]
6. Biodegradable Thermosensitive PLGA-PEG-PLGA Polymer for Non-irritating and Sustained Ophthalmic Drug Delivery.
Chan PS; Xian JW; Li Q; Chan CW; Leung SSY; To KKW
AAPS J; 2019 Apr; 21(4):59. PubMed ID: 31020458
[TBL] [Abstract][Full Text] [Related]
7. Corneal Pharmacokinetics of Voriconazole and Posaconazole following Intrastromal Injection and Posaconazole Eye Drops Instillation in Rats.
Gueudry J; Le Goff L; Lamoureux F; Pereira T; Levefre S; Razakandrainibe R; Costa D; Ballet JJ; Muraine M; Favennec L
Curr Eye Res; 2020 Nov; 45(11):1369-1372. PubMed ID: 32228098
[No Abstract] [Full Text] [Related]
8. Comparison of the Ocular Penetration and Pharmacokinetics Between Natamycin and Voriconazole After Topical Instillation in Rabbits.
Zhao X; Tong Y; Wang X; Zhang X; Chen S; Lu H
J Ocul Pharmacol Ther; 2018; 34(6):460-467. PubMed ID: 29792548
[TBL] [Abstract][Full Text] [Related]
9. Optimized molecular imprints in gamma-irradiated collagen shields of an antifungal drug: In vitro characterization, in-vivo bioavailability enhancement.
Abouelatta SM; Sheta AI; Ibrahim RR
Eur J Pharm Biopharm; 2021 Sep; 166():135-143. PubMed ID: 34166761
[TBL] [Abstract][Full Text] [Related]
10. Voriconazole concentration in human aqueous humor and plasma during topical or combined topical and systemic administration for fungal keratitis.
Thiel MA; Zinkernagel AS; Burhenne J; Kaufmann C; Haefeli WE
Antimicrob Agents Chemother; 2007 Jan; 51(1):239-44. PubMed ID: 17060517
[TBL] [Abstract][Full Text] [Related]
11. Sustained intravitreal delivery of dexamethasone using an injectable and biodegradable thermogel.
Zhang L; Shen W; Luan J; Yang D; Wei G; Yu L; Lu W; Ding J
Acta Biomater; 2015 Sep; 23():271-281. PubMed ID: 26004219
[TBL] [Abstract][Full Text] [Related]
12. Corneal and aqueous humor concentrations of amphotericin B using three different routes of administration in a rabbit model.
Qu L; Li L; Xie H
Ophthalmic Res; 2010; 43(3):153-8. PubMed ID: 19887881
[TBL] [Abstract][Full Text] [Related]
13. Tumor microenvironment-labile polymer-doxorubicin conjugate thermogel combined with docetaxel for in situ synergistic chemotherapy of hepatoma.
Zhang Y; Zhang J; Xu W; Xiao G; Ding J; Chen X
Acta Biomater; 2018 Sep; 77():63-73. PubMed ID: 30006312
[TBL] [Abstract][Full Text] [Related]
14. Equine keratomycosis in Switzerland: a retrospective evaluation of 35 horses (January 2000-August 2011).
Voelter-Ratson K; Pot SA; Florin M; Spiess BM
Equine Vet J; 2013 Sep; 45(5):608-12. PubMed ID: 23489138
[TBL] [Abstract][Full Text] [Related]
15. Ocular distribution and toxicity of intravitreal injection of triamcinolone acetonide in normal equine eyes.
Yi NY; Davis JL; Salmon JH; Gilger BC
Vet Ophthalmol; 2008 Sep; 11 Suppl 1():15-9. PubMed ID: 19046265
[TBL] [Abstract][Full Text] [Related]
16. Comparison of voriconazole concentration in the aqueous humor and vitreous between non-scraped and scraped corneal epithelium groups after topical 1% voriconazole application.
Wei LC; Tsai TC; Tsai HY; Wang CY; Shen YC
Curr Eye Res; 2010 Jul; 35(7):573-9. PubMed ID: 20597643
[TBL] [Abstract][Full Text] [Related]
17. Corneal stromal abscessation in two horses treated with intracorneal and subconjunctival injection of 1% voriconazole solution.
Tsujita H; Plummer CE
Vet Ophthalmol; 2013 Nov; 16(6):451-8. PubMed ID: 23228013
[TBL] [Abstract][Full Text] [Related]
18. In vitro susceptibility patterns of Aspergillus and Fusarium species isolated from equine ulcerative keratomycosis cases in the midwestern and southern United States with inclusion of the new antifungal agent voriconazole.
Pearce JW; Giuliano EA; Moore CP
Vet Ophthalmol; 2009; 12(5):318-24. PubMed ID: 19751493
[TBL] [Abstract][Full Text] [Related]
19. Topically applied 1% voriconazole induces dysplastic changes on the ocular surface: animal study.
Arikan G; Karatas E; Lebe B; Ayhan Z; Utine CA; Kutsoylu OE; Gunenc U; Yilmaz O
Cutan Ocul Toxicol; 2018 Dec; 37(4):328-331. PubMed ID: 29633868
[TBL] [Abstract][Full Text] [Related]
20. An injectable thermosensitive polymeric hydrogel for sustained release of Avastin® to treat posterior segment disease.
Xie B; Jin L; Luo Z; Yu J; Shi S; Zhang Z; Shen M; Chen H; Li X; Song Z
Int J Pharm; 2015 Jul; 490(1-2):375-83. PubMed ID: 26027491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
